Celldex Therapeutics, Inc.;University Of Iowa Research Foundation
发明人:
Richard J.H. SMITH,Yuzhou ZHANG,Henry C. MARSH
申请号：
US15071504
公开号：
US20160184392A1
申请日:
2016.03.16
申请国别(地区):
US
年份:
2016
代理人:
摘要：
A method is disclosed for treating nephropathies involving undesired alternative pathway complement activation by administration of a complement inhibitory protein such as soluble complement receptor type I (sCR1).
